Novartis Ag (NVS) Deferred Taxes (2009 - 2019)

Novartis Ag (NVS) has 4 years of Deferred Taxes data on file, last reported at -$5.6 billion in Q2 2019.

• Quarterly Deferred Taxes fell 172.71% year-over-year to -$5.6 billion in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $3.0 billion (down 64.85% YoY) and the FY2017 annual result came in at $7.7 billion, up 15.0% from the prior year.
• Deferred Taxes declined to -$5.6 billion in Q2 2019 per NVS's latest filing, from $7.7 billion in the prior quarter.
• The five-year high for Deferred Taxes was $7.7 billion in Q2 2018, with the low at -$5.6 billion in Q2 2019.
• Average Deferred Taxes over 3 years is $1.0 billion, with a median of $936.0 million recorded in 2016.
• The widest YoY moves for Deferred Taxes: up 172.71% in 2019, down 172.71% in 2019.
• Novartis Ag's Deferred Taxes stood at $936.0 million in 2016, then soared by 725.64% to $7.7 billion in 2018, then slumped by 172.71% to -$5.6 billion in 2019.
• Business Quant data shows NVS's Deferred Taxes at -$5.6 billion in Q2 2019, $7.7 billion in Q2 2018, and $936.0 million in Q4 2016.